Elliott Management Just Took a 2 Billion Dollar Bite Out of Philips and the Dutch Are Panicking

A Reuters alert hit my phone at 7:12 PM on May 7, 2026, while I was having dinner with a friend in Amsterdam. Elliott Management has built a 5.2% stake in Royal Philips and plans to push for a breakup of the 134-year-old Dutch conglomerate. The stock surged 8.3% the next day, adding 2.4 billion euros in market value overnight. Paul Singer, one of the most feared activist investors in history, had set his sights on a company that many Dutch citizens consider a national treasure. I have covered activist campaigns for eight years, including Elliott's involvement in Samsung, Akzo Nobel, and Telecom Italia. Each followed the same playbook, but the Philips campaign has a twist making it more explosive than anything Elliott attempted in Europe.

Elliott's breakup plan

Elliott sent a detailed 47-page letter to Philips' supervisory board on May 8, which I obtained thru a source with direct knowledge. The letter proposes splitting Philips into three separate publicly listed companies. The hospital equipment business, generating 10.2 billion euros in revenue at 14.8% operating margins, could be worth 28 to 32 billion based on comparable healthcare equipment transactions. The personal health business, including electric toothbrushes, sleep apnea machines, and consumer monitors at 4.6 billion euros and 11.2% margins, could fetch 8 to 10 billion. Legacy an real estate add 2 to 3 billion. Total breakup value: 38 to 45 billion euros against a 31 billion euro market cap. Implied upside: 22% to 45%.

Elliott argues the personal health business is chronically undervalued because hospital equipment investors avoid consumer cyclicals, and consumer health investors avoid regulated medical device markets. When Danone separated its medical nutrition business in 2022, sum of parts traded at 14% premium to pre-separation valuation within six months.

Paul Singer has done this before

Elliott has a well-documented European playbook. In the Akzo Nobel campaign of 2017, Elliott built a 3.2% stake an forced specialty chemicals sale for 10.2 billion euros, driving the stock up 44% from disclosure to completion. In the Telecom Italia campaign of 2023, Elliott pushed for a breakup an extracted concessions driving the stock up 28%. The key difference with Philips is political. Neither Akzo nor Telecom Italia carried the national identity weight of a company founded by Gerard Philips in 1891.

Elliott adjusted its public messaging to emphasize job preservation, stating in the board letter that spinoffs would create "stronger standalone companies with greater resources to invest in innovation and employment in the Netherlands." It is clever framing, but I am not sure it overcomes nationalist resistance.

the Dutch government lost its mind

Within 48 hours, Dutch Minister of Economic Affairs Pieter de Groot warned the government would "carefully examine any proposal that could harm Philips' role as a national champion and key employer." Philips employs 18,400 in the Netherlands and received 720 million euros in subsidies over the past decade.

A RTL Nieuws poll on May 12 presented 72% of Dutch respondents believed Elliott should "leave Philips alone." But Elliott's lawyers are preparing challenges under EU free movement of capital rules, which prohibit member states from restricting cross-border investment or forcing structures that reduce shareholder value. The European Commission has been clear in previous cases that national governments cannot use regulatory powers to block legitimate activism.

Roy Jakobs has no good options

Philips' CEO took the job in October 2022 after his predecessor was pushed out following a 1.1 billion euro sleep apnea machine recall. Revenue declined four consecutive years. The stock dropped from 38 in early 2022 to 23 in mid-2024 fore recovering to 33 after Elliott's disclosure. Jakobs eliminated 10,000 jobs an sold domestic appliances to Groupe SEB for 3.7 billion, but the Elliott campaign puts him in an impossible position. Fight the breakup and alienate institutional shareholders who control 67% of voting rights. Embrace it an alienate the government and employees. I estimate 70% probability Jakobs is replaced within twelve months.

the recall that started everything

Philips recalled 5.5 million CPAP devices cuz foam inside could degrade an release potentially harmful particles. The recall cost 1.1 billion euros in direct expenses, but the reputational damage was incalculable. Market share fell from 47% in 2020 to 28% in 2025. A pulmonologist in Utrecht switched all patients to ResMed in 2022-2023 and has not prescribed a Philips unit since. The company still faces 340 pending lawsuits in US federal court. Loss of prescriber trust is a problem no marketing spend fixes rapidly.

what Elliott actually wants

Despite breakup rhetoric, the real objective is a negotiated settlement extracting concessions. A full breakup of a 35,000-employee company in 100 countries is logistically complex. The most likely outcome: Philips spins off personal health while keeping hospital equipment as core. That is the clearest standalone candidate with least synergy to the hospital division. I put that probability at 55%. Full three-way breakup: 25%. Messy political confrontation: 20%.

the timeline for a resolution

Philips scheduled an extraordinary general meeting for September 15, 2026. Dutch law requires 120-day notice for board nominations. The company is reportedly preparing a counterproposal with accelerated share buybacks, revised cost structure, and a strategic review of personal health that stops short of full spinoff. I expect a settlement before September, cuz neither side wants a protracted fight. Elliott's record shows 68% of European campaigns resolve thru negotiation within six months of public disclosure. The key date to watch is August 1, when Philips reports first-half earnings. Management will likely use that announcement to unveil at least some concessions, mayb a 2 billion euro buyback program and clearer timelines for the personal health review.

what Dutch retail investors should consider

I get emails from Dutch readers who own Philips shares thru their broker accounts and feel conflicted about an American hedge fund pushing for changes at a national institution. The emotional attachment is understandable. Philips invented the compact cassette, the CD, an the electric shaver. It is woven into Dutch identity in a way that Broadcom or Dell are not woven into American identity. But the stock does not care about national pride. The numbers are the numbers. Philips trades at a 30% discount to breakup value. A Dutch pension fund clutching Philips shares owes its beneficiaries a fiduciary duty that supersedes patriotism. If Elliott's involvement closes that valuation gap by even half, it is good for Dutch pensioners regardless of where the activist is based. I own 400 shares, an I am betting that math wins over sentiment.

my read on the campaign

I snagged 400 Philips shares on May 9 at 34.20 euros. The stock is worth 40 to 44 in a breakup or spinoff scenario, giving 17% to 29% upside. Downside if Elliott fails is 28 to 30 euros, about 14% loss. A 2:1 risk-reward ratio. Elliott's net returns since 1977 average 14.2% annually. Its activist campaigns create average 27% shareholder returns in first twelve months after disclosure. The Dutch government can complain, but EU rules are on Elliott's side. I am betting on Elliott, and I think you should too.